Adrafinil vs Fasoracetam

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

AdrafinilFasoracetam
CategoryNootropicsNootropics
Standard Dose300-600 mg once daily (for educational context — unregulated prodrug of a prescription medication)20-100 mg 1-3 times daily (sublingual or oral)
TimingEarly morning on an empty stomach for faster hepatic conversion. Onset delayed 60-90 minutes. Avoid afternoon/evening dosing due to long effective duration.Morning and afternoon. Sublingual administration may provide faster onset and higher bioavailability. With or without food.
Cycle DurationShort-term or intermittent use strongly preferred. Avoid continuous daily use exceeding 3 months without liver function monitoring.Cycles of 4-8 weeks on, 2-4 weeks off. Limited long-term safety data.
Evidence Levelmoderate_humananimal_plus_anecdotal
A

Adrafinil

Nootropics

Mechanism

Inactive prodrug that is hepatically metabolized to modafinil (via hepatic amidase enzymes) and its inactive acid metabolite modafinilic acid. The active metabolite modafinil then exerts its effects as a DAT inhibitor with downstream orexinergic, histaminergic, and noradrenergic activation. Conversion is incomplete — approximately 33-50% of adrafinil is converted to modafinil, with the remainder forming inactive metabolites. The hepatic first-pass metabolism means onset is delayed (60-90 minutes vs. 30-60 minutes for modafinil).

Standard Dosing

300-600 mg once daily (for educational context — unregulated prodrug of a prescription medication)

Timing

Early morning on an empty stomach for faster hepatic conversion. Onset delayed 60-90 minutes. Avoid afternoon/evening dosing due to long effective duration.

Cycle Duration

Short-term or intermittent use strongly preferred. Avoid continuous daily use exceeding 3 months without liver function monitoring.

Side Effects

  • All modafinil side effects apply
  • Elevated liver enzymes (ALT/AST)
  • Potential hepatotoxicity with chronic use
  • Skin reactions
  • GI distress (more common than with modafinil due to hepatic metabolism)

Contraindications

  • Hepatic impairment of any severity
  • Concurrent hepatotoxic medication
  • All contraindications for modafinil apply (cardiac conditions, anxiety disorders, pregnancy)
  • History of liver disease or elevated liver enzymes

Best Stacking Partners

L-TheanineAlpha-GPCMilk Thistle (hepatoprotective adjunct)
B

Fasoracetam

Nootropics

Mechanism

Non-classical racetam that modulates all three groups of metabotropic glutamate receptors (mGluR Groups I, II, and III) and upregulates GABA-B receptors — a unique mechanism that distinguishes it from other racetams. Also enhances high-affinity choline uptake (HACU) and stimulates acetylcholine release. Does not significantly affect adrenergic, serotonergic, or dopaminergic receptors. The GABA-B upregulation is particularly notable as it may counteract GABA-B receptor downregulation caused by phenibut or baclofen tolerance.

Standard Dosing

20-100 mg 1-3 times daily (sublingual or oral)

Timing

Morning and afternoon. Sublingual administration may provide faster onset and higher bioavailability. With or without food.

Cycle Duration

Cycles of 4-8 weeks on, 2-4 weeks off. Limited long-term safety data.

Side Effects

  • Headache
  • Fatigue
  • GI discomfort
  • Irritability
  • Brain fog (paradoxical, at excessive doses)

Contraindications

  • Known hypersensitivity to racetams
  • Pregnancy and lactation (no safety data)
  • Severe renal or hepatic impairment

Best Stacking Partners

Alpha-GPCCDP-CholineAniracetamColuracetam

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →